~~<i id='5FEF767CCC'><strike id='5FEF767CCC'><tt id='5FEF767CCC'><pre id='5FEF767CCC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：explore 2025-09-02 08:19:48 - browse：861

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Obesity experts on risks of Wegovy, Ozempic weight loss drugs

knowledge

hotspot

Wikipedia

hotspot

AlogosignoutsideoftheheadquartersofSareptaTherapeuticsinCambridge,Mass.KristofferTripplaar/SipaviaAP

WSS

My daughter's legacy lives on through her writing, phage therapy

The system is set up to fail children with medical complexity

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Teladoc has a new CEO, but challenges remain the same

Why drug prescriptions should include diagnoses

focus

hotspot

knowledge

Virginia high school admissions case could be legal follow

Teladoc has a new CEO, but challenges remain the same

Moonlake's readout produced a cash windfall. Risks remain

NIH tests clinical research in primary care with $30 million program

Apple is now the first public company to be valued at $3 trillion

In areas with more Black doctors, Black people live longer

Alkermes shareholders re

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Malaria cases in Florida and Texas: Here’s what you need to know

3 hurdles to bringing medical devices to the U.S. market

hotspot

The story of mRNA: From a loose idea to a tool that may help curb Covid

The story of mRNA: From a loose idea to a tool that may help curb Covid

Curing rare childhood diseases will falter unless Congress steps up

How faith leaders like me can help address America's obesity epidemic

3 hurdles to bringing medical devices to the U.S. market

Teladoc has a new CEO, but challenges remain the same

Wikipedia

Wikipedia

Wikipedia

hotspot